Ig class | Type of test | No. of positive sera in | Sensitivity (95% CI) | Specificity (95% CI) | AUC | |
---|---|---|---|---|---|---|
Patientsa (54) | Controlsb (86) | |||||
M | rAtpD | 38 | 3 | 70% (58%-83%) | 97% (93%-100%) | 0.923 |
M | rP1-C | 38 | 9 | 70% (58%-83%) | 90% (83%-96%) | 0.897 |
M | rAtpD-rP1-C | 40 | 5 | 74% (60%-80%) | 94% (89%-99%) | 0.925 |
M | Ani Labsystems | 39 | 7 | 72% (60%-84%) | 92% (81%-97%) | 0.824 |
A | rAtpD | 30 | 5 | 56% (42%-69%) | 94% (89%-99%) | 0.842 |
A | rP1-C | 27 | 7 | 50% (37%-63%) | 92% (86%-98%) | 0.775 |
A | rAtpD-rP1-C | 31 | 8 | 57% (44%-71%) | 91% (89%-99%) | 0.842 |
A | Ani Labsystems | 46 | 38 | 85% (77%-95%) | 56% (45%-66%) | 0.801 |
G | rAtpD | 42 | 3 | 78% (67%-89%) | 97% (93%-100%) | 0.943 |
G | rP1-C | 37 | 9 | 69% (56%-81%) | 90% (83%-96%) | 0.869 |
G | rAtpD-rP1-C | 43 | 5 | 80% (69%-90%) | 94% (89%-99%) | 0.925 |
G | Ani Labsystems | 52 | 61 | 96% (91%-100%) | 29% (19%-39%) | 0.663 |